NYXH vs. KIDS, SIBN, IRMD, BVS, NNOX, ZJYL, TMCI, AXGN, SGHT, and TCMD
Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include OrthoPediatrics (KIDS), SI-BONE (SIBN), Iradimed (IRMD), Bioventus (BVS), Nano-X Imaging (NNOX), Jin Medical International (ZJYL), Treace Medical Concepts (TMCI), AxoGen (AXGN), Sight Sciences (SGHT), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.
Nyxoah (NASDAQ:NYXH) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, community ranking, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.
69.1% of OrthoPediatrics shares are held by institutional investors. 17.1% of Nyxoah shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
OrthoPediatrics has higher revenue and earnings than Nyxoah. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.
Nyxoah currently has a consensus price target of $17.80, indicating a potential upside of 113.69%. OrthoPediatrics has a consensus price target of $44.75, indicating a potential upside of 37.27%. Given Nyxoah's stronger consensus rating and higher possible upside, equities research analysts clearly believe Nyxoah is more favorable than OrthoPediatrics.
Nyxoah has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.
In the previous week, OrthoPediatrics had 2 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for OrthoPediatrics and 1 mentions for Nyxoah. OrthoPediatrics' average media sentiment score of 0.94 beat Nyxoah's score of 0.93 indicating that OrthoPediatrics is being referred to more favorably in the news media.
OrthoPediatrics has a net margin of -13.58% compared to Nyxoah's net margin of -843.49%. OrthoPediatrics' return on equity of -5.12% beat Nyxoah's return on equity.
OrthoPediatrics received 275 more outperform votes than Nyxoah when rated by MarketBeat users. However, 67.39% of users gave Nyxoah an outperform vote while only 64.42% of users gave OrthoPediatrics an outperform vote.
Summary
OrthoPediatrics beats Nyxoah on 11 of the 18 factors compared between the two stocks.
Get Nyxoah News Delivered to You Automatically
Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
Free NYXH Stock Alerts